Major Study Establishes Safety of New Stroke Drug

In 1996, Alteplase, a clot dissolving drug also known as tPA became the first available treatment for the most common type of stroke. It revolutionized the treatment of stroke around the world. https://www.ucalgary.ca/news/ucalgary-researchers-calgary-stroke-program-make-another-breakthrough-treatment-stroke

Selected Patients May Benefit from Later Stroke Treatment

A new study has demonstrated that some strokes may be treated later than was previously thought. The EXTEND study, performed in Australia, treated patients with the clot dissolving medication Alteplase (tPA) between 4.5 and 9 hours after the start of the stroke, including patients that noticed their symptoms after waking from sleep. More patients who … Read more